Trademark: 86825501
Word
UNYQLA
Status
Dead
Status Code
606
Status Date
Monday, January 30, 2017
Serial Number
86825501
Mark Type
4000
Filing Date
Thursday, November 19, 2015
Published for Opposition
Tuesday, May 3, 2016
Abandoned Date
Monday, January 30, 2017

Trademark Owner History
Glaxo Group Limited - Owner At Publication

Classifications
5 Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines

Trademark Events
Jan 30, 2017
Abandonment Notice Mailed - No Use Statement Filed
Jan 30, 2017
Abandonment - No Use Statement Filed
Jun 28, 2016
Noa E-Mailed - Sou Required From Applicant
May 3, 2016
Official Gazette Publication Confirmation E-Mailed
May 3, 2016
Published For Opposition
Apr 13, 2016
Notification Of Notice Of Publication E-Mailed
Mar 29, 2016
Electronic Record Review Complete
Mar 25, 2016
On Hold - Electronic Record Review Required
Mar 15, 2016
Approved For Pub - Principal Register
Mar 11, 2016
Assigned To Examiner
Nov 24, 2015
New Application Office Supplied Data Entered In Tram
Nov 23, 2015
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24